Other Species / Isoforms
  PSEN2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S7-p
_MLTFMAsDsEEEVC
Upstream
3 0
Kinase, in vitro:
  • CK2A1 (human)
PSEN2 (human) _MLTFMAsDsEEEVC S7-p
PSEN2 (mouse) _MLAFMASDSEEEVC S7
PSEN2 (rat) _MLTFMASDSEEEVC S7
S9-p
LTFMAsDsEEEVCDE
Upstream
2 0
Kinase, in vitro:
  • CK2A1 (human)
PSEN2 (human) LTFMAsDsEEEVCDE S9-p
PSEN2 (mouse) LAFMASDSEEEVCDE S9
PSEN2 (rat) LTFMASDSEEEVCDE S9
T18
EEVCDERTsLMsAEs
0 1
PSEN2 (human) EEVCDERTsLMsAEs T18
PSEN2 (mouse) EEVCDERtsLMsAEs T18-p
PSEN2 (rat) EEVCDERTSLMsAEs T18
S19-p
EVCDERTsLMsAEsP
Upstream
Downstream
2 1
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • AurA (human)
PSEN2 (human) EVCDERTsLMsAEsP S19-p
PSEN2 (mouse) EVCDERtsLMsAEsP S19-p
PSEN2 (rat) EVCDERTSLMsAEsP S19
S22-p
DERTsLMsAEsPtPR
Upstream
0 21
Treatment
  • nocodazole
PSEN2 (human) DERTsLMsAEsPtPR S22-p
PSEN2 (mouse) DERtsLMsAEsPtsR S22-p
PSEN2 (rat) DERTSLMsAEsPTSR S22-p
S25-p
TsLMsAEsPtPRSCQ
Upstream
0 32
Treatment
  • nocodazole
PSEN2 (human) TsLMsAEsPtPRSCQ S25-p
PSEN2 (mouse) tsLMsAEsPtsRsCQ S25-p
PSEN2 (rat) TSLMsAEsPTSRSCQ S25-p
T27-p
LMsAEsPtPRSCQEG
0 2
PSEN2 (human) LMsAEsPtPRSCQEG T27-p
PSEN2 (mouse) LMsAEsPtsRsCQEG T27-p
PSEN2 (rat) LMsAEsPTSRSCQDS T27
P28
MsAEsPtPRSCQEGR
0 1
PSEN2 (human) MsAEsPtPRSCQEGR P28
PSEN2 (mouse) MsAEsPtsRsCQEGR S28-p
PSEN2 (rat) MsAEsPTSRSCQDSR S28
S30
AEsPtPRSCQEGRQG
0 4
PSEN2 (human) AEsPtPRSCQEGRQG S30
PSEN2 (mouse) AEsPtsRsCQEGRPG S30-p
PSEN2 (rat) AEsPTSRSCQDSRPG S30
N43
QGPEDGENTAQWRsQ
0 1
PSEN2 (human) QGPEDGENTAQWRsQ N43
PSEN2 (mouse) PGPEDGEsTAQWRtQ S43-p
PSEN2 (rat) PGPEDGENTAQWRSQ N43
S49-p
ENTAQWRsQENEEDG
0 4
PSEN2 (human) ENTAQWRsQENEEDG S49-p
PSEN2 (mouse) EsTAQWRtQEsEEDC T49-p
PSEN2 (rat) ENTAQWRSQENEDDC S49
N52
AQWRsQENEEDGEED
0 9
PSEN2 (human) AQWRsQENEEDGEED N52
PSEN2 (mouse) AQWRtQEsEEDCEED S52-p
PSEN2 (rat) AQWRSQENEDDCEED N52
S66
DPDRYVCSGVPGRPP
0 1
PSEN2 (human) DPDRYVCSGVPGRPP S66
PSEN2 (mouse) DPDRYACsGAPGRPS S66-p
PSEN2 (rat) DPDHYACSGVPGRPS S66
K115-ub
SVRFYTEkNGQLIYT
0 2
PSEN2 (human) SVRFYTEkNGQLIYT K115-ub
PSEN2 (mouse) SVRFYTEKNGQLIYT K115
PSEN2 (rat) SVRFYTEKNGQLIYT K115
Y294-p
PIFPALIySSAMVWT
0 1
PSEN2 (human) PIFPALIySSAMVWT Y294-p
PSEN2 (mouse) PIFPALIYSSAMVWT Y294
PSEN2 (rat) PIFPALIYSSAMVWT Y294
K306-ac
VWTVGMAkLDPSSQG
0 1
PSEN2 (human) VWTVGMAkLDPSSQG K306-ac
PSEN2 (mouse) VWTVGMAKLDPSSQG K306
PSEN2 (rat) VWTVGMAKLDPSSQG K306
S327-p
DPEMEEDsYDsFGEP
Upstream
Downstream
2 0
Effects on Modified Protein
  • protein stabilization
Effects on Biological Processes:
  • apoptosis, inhibited
Kinase, in vitro:
  • CK1D (human)
PSEN2 (human) DPEMEEDsYDsFGEP S327-p
PSEN2 (mouse) DPEMEEDSYDSFGEP S327
PSEN2 (rat) DPEMEEDSYDSFGEP S327
S330-p
MEEDsYDsFGEPsYP
Upstream
Downstream
2 0
Effects on Modified Protein
  • protein stabilization
Effects on Biological Processes:
  • apoptosis, inhibited
Kinase, in vitro:
  • CK1D (human)
  • CK2A1 (human)
PSEN2 (human) MEEDsYDsFGEPsYP S330-p
PSEN2 (mouse) MEEDSYDSFGEPSYP S330
PSEN2 (rat) MEEDSYDSFGEPSYP S330
S335-p
YDsFGEPsYPEVFEP
Upstream
1 0
Kinase, in vitro:
  • CK2A1 (human)
PSEN2 (human) YDsFGEPsYPEVFEP S335-p
PSEN2 (mouse) YDSFGEPSYPEAFEA S335
PSEN2 (rat) YDSFGEPSYPEAFEA S335